Tenaya Therapeutics, Inc. (TNYA)
NASDAQ: TNYA · Real-Time Price · USD
0.6424
-0.0494 (-7.14%)
At close: Mar 28, 2025, 4:00 PM
0.6400
-0.0024 (-0.37%)
After-hours: Mar 28, 2025, 7:50 PM EDT
Tenaya Therapeutics Stock Forecast
TNYA's stock price has decreased by -87.55% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Tenaya Therapeutics stock have an average target of 8.60, with a low estimate of 5.00 and a high estimate of 18. The average target predicts an increase of 1,238.73% from the current stock price of 0.64.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Tenaya Therapeutics stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 4 | 4 |
| Buy | 2 | 2 | 1 | 1 | 1 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 4 | 4 | 5 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $18 → $6 | Strong Buy | Maintains | $18 → $6 | +834.00% | Mar 13, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $15 → $5 | Buy | Maintains | $15 → $5 | +678.33% | Mar 12, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $18 → $9 | Strong Buy | Maintains | $18 → $9 | +1,301.00% | Mar 12, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $18 → $5 | Strong Buy | Maintains | $18 → $5 | +678.33% | Mar 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +2,701.99% | Feb 3, 2025 |
Financial Forecast
Revenue This Year
n/a
from 1.42B
Revenue Next Year
n/a
EPS This Year
-0.76
from -1.31
EPS Next Year
-0.78
from -0.76
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 15.8M | 73.6M | 544.6M | ||
| Avg | 3.4M | 22.2M | 271.8M | ||
| Low | n/a | n/a | 89.4M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -98.9% | 2,096.5% | 2,356.9% | ||
| Avg | -99.8% | 561.5% | 1,125.9% | ||
| Low | - | - | 303.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.54 | -0.58 | 2.48 | ||
| Avg | -0.76 | -0.78 | 0.16 | ||
| Low | -1.23 | -1.22 | -0.89 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.